Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arnold Louie

Showing results (1-10 of 96) with videos related to

Pageof 10
Sort By:
Antimicrobial Agents and Chemotherapy|March 16, 2011
Optimization of aminoglycoside therapyG L Drusano, Arnold Louie
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|February 4, 2019
Breakpoint determination when multiple organisms are tested for effect targetsG L Drusano, Arnold Louie
Antimicrobial Agents and Chemotherapy|September 14, 2011
Impact of granulocytes on the antimicrobial effect of tedizolid in a mouse thigh infection modelG L Drusano, Weiguo Liu, Robert Kulawy, et al.
Antimicrobial Agents and Chemotherapy|December 30, 2015
Suppression of Emergence of Resistance in Pathogenic Bacteria: Keeping Our Powder Dry, Part 2G L Drusano, William Hope, Alasdair MacGowan, et al.
Antimicrobial Agents and Chemotherapy|April 20, 2011
In vivo pharmacodynamics of torezolid phosphate (TR-701), a new oxazolidinone antibiotic, against methicillin-susceptible and methicillin-resistant Staphylococcus aureus strains in a mouse thigh infection modelArnold Louie, Weiguo Liu, Robert Kulawy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 20, 2006
The crisis of resistance: identifying drug exposures to suppress amplification of resistant mutant subpopulationsG L Drusano, Arnold Louie, Mark Deziel, et al.
Antimicrobial Agents and Chemotherapy|December 30, 2015
Suppression of Emergence of Resistance in Pathogenic Bacteria: Keeping Our Powder Dry, Part 1G L Drusano, Arnold Louie, Alasdair MacGowan, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2007
Impact of resistance selection and mutant growth fitness on the relative efficacies of streptomycin and levofloxacin for plague therapyArnold Louie, Mark R Deziel, Weiguo Liu, et al.
Antimicrobial Agents and Chemotherapy|July 29, 2005
Pharmacodynamic evidence that ciprofloxacin failure against tuberculosis is not due to poor microbial kill but to rapid emergence of resistanceTawanda Gumbo, Arnold Louie, Mark R Deziel, et al.
Antimicrobial Agents and Chemotherapy|April 15, 2009
Pharmacodynamics of levofloxacin in a murine pneumonia model of Pseudomonas aeruginosa infection: determination of epithelial lining fluid targetsArnold Louie, Christine Fregeau, Weiguo Liu, et al.
Pageof 10

Showing results (1-10 of 96) with videos related to

Sort By:
Pageof 10
Antimicrobial Agents and Chemotherapy|March 16, 2011
Optimization of aminoglycoside therapyG L Drusano, Arnold Louie
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|February 4, 2019
Breakpoint determination when multiple organisms are tested for effect targetsG L Drusano, Arnold Louie
Antimicrobial Agents and Chemotherapy|September 14, 2011
Impact of granulocytes on the antimicrobial effect of tedizolid in a mouse thigh infection modelG L Drusano, Weiguo Liu, Robert Kulawy, et al.
Antimicrobial Agents and Chemotherapy|December 30, 2015
Suppression of Emergence of Resistance in Pathogenic Bacteria: Keeping Our Powder Dry, Part 2G L Drusano, William Hope, Alasdair MacGowan, et al.
Antimicrobial Agents and Chemotherapy|April 20, 2011
In vivo pharmacodynamics of torezolid phosphate (TR-701), a new oxazolidinone antibiotic, against methicillin-susceptible and methicillin-resistant Staphylococcus aureus strains in a mouse thigh infection modelArnold Louie, Weiguo Liu, Robert Kulawy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 20, 2006
The crisis of resistance: identifying drug exposures to suppress amplification of resistant mutant subpopulationsG L Drusano, Arnold Louie, Mark Deziel, et al.
Antimicrobial Agents and Chemotherapy|December 30, 2015
Suppression of Emergence of Resistance in Pathogenic Bacteria: Keeping Our Powder Dry, Part 1G L Drusano, Arnold Louie, Alasdair MacGowan, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2007
Impact of resistance selection and mutant growth fitness on the relative efficacies of streptomycin and levofloxacin for plague therapyArnold Louie, Mark R Deziel, Weiguo Liu, et al.
Antimicrobial Agents and Chemotherapy|July 29, 2005
Pharmacodynamic evidence that ciprofloxacin failure against tuberculosis is not due to poor microbial kill but to rapid emergence of resistanceTawanda Gumbo, Arnold Louie, Mark R Deziel, et al.
Antimicrobial Agents and Chemotherapy|April 15, 2009
Pharmacodynamics of levofloxacin in a murine pneumonia model of Pseudomonas aeruginosa infection: determination of epithelial lining fluid targetsArnold Louie, Christine Fregeau, Weiguo Liu, et al.
Pageof 10